Walt Addison Linscott

General Counsel, Cocrystal Pharma, Inc.

Companies

Indaptus Therapeutics, Inc.Chief operating officer Jan 23, 2024 to now¹
Indaptus Therapeutics, Inc.Chief Business Officer Aug 2, 2021 to Jan 20, 2023²
Cocrystal Pharma, Inc.General counsel Jul 23, 2015 to Jul 23, 2015³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Indaptus Therapeutics, Inc. INDP54,426 shares⁴$155.1K at $2.85Dec 22, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 22, 2025Granted 54,421 shares at $2.03 of Indaptus Therapeutics, Inc.⁴
Sep 7, 2022Bought 150 shares at $2.62 of Indaptus Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARIndaptus Therapeutics, Inc., Chief operating officer
2
SEC EDGARIndaptus Therapeutics, Inc., Chief Business Officer
3
SEC EDGARCocrystal Pharma, Inc., General counsel
4
SEC EDGARIndaptus Therapeutics, Inc. shares after the filing of Dec 22, 2025
5
SEC EDGARForm 4 filed Sep 9, 2022